Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery.

Husain-Syed F, Ferrari F, Sharma A, Hinna Danesi T, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzì GM, De Rosa S, Muciño Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Zanella M, Brendolan A, Giavarina D, Salvador L, Bellomo R, Rosner MH, Kellum JA, Ronco C.

Nephrol Dial Transplant. 2018 Jul 19. doi: 10.1093/ndt/gfy227. [Epub ahead of print]

PMID:
30053231
2.

Lipid-Protein Interactions Are Unique Fingerprints for Membrane Proteins.

Corradi V, Mendez-Villuendas E, Ingólfsson HI, Gu RX, Siuda I, Melo MN, Moussatova A, DeGagné LJ, Sejdiu BI, Singh G, Wassenaar TA, Delgado Magnero K, Marrink SJ, Tieleman DP.

ACS Cent Sci. 2018 Jun 27;4(6):709-717. doi: 10.1021/acscentsci.8b00143. Epub 2018 Jun 13.

3.

Structure of Transmembrane Helix 8 and Possible Membrane Defects in CFTR.

Corradi V, Gu RX, Vergani P, Tieleman DP.

Biophys J. 2018 Apr 24;114(8):1751-1754. doi: 10.1016/j.bpj.2018.03.003.

4.

Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D).

Dozio E, Corradi V, Proglio M, Vianello E, Menicanti L, Rigolini R, Caprara C, de Cal M, Corsi Romanelli MM, Ronco C.

Diabetes Res Clin Pract. 2018 Jun;140:9-17. doi: 10.1016/j.diabres.2018.03.017. Epub 2018 Mar 26. Review.

PMID:
29596954
5.

Coarse-grained molecular dynamics simulations reveal lipid access pathways in P-glycoprotein.

Barreto-Ojeda E, Corradi V, Gu RX, Tieleman DP.

J Gen Physiol. 2018 Feb 6. pii: jgp.201711907. doi: 10.1085/jgp.201711907. [Epub ahead of print]

6.

Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation.

Husain-Syed F, Ferrari F, Sharma A, Danesi TH, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzì GM, De Rosa S, Muciño Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Zanella M, Brendolan A, Giavarina D, Salvador L, Bellomo R, Rosner MH, Kellum JA, Ronco C.

Ann Thorac Surg. 2018 Apr;105(4):1094-1101. doi: 10.1016/j.athoracsur.2017.12.034. Epub 2018 Jan 31.

PMID:
29382510
7.

Routine adoption of TIMP2 and IGFBP7 biomarkers in cardiac surgery for early identification of acute kidney injury.

Levante C, Ferrari F, Manenti C, Husain-Syed F, Scarpa M, Hinna Danesi T, De Cal M, Corradi V, Virzì GM, Brendolan A, Nalesso F, Bezerra P, Lopez-Giacoman S, Samoni S, Senzolo M, Giavarina D, Salvador L, Bonato R, De Rosa S, Rettore E, Ronco C.

Int J Artif Organs. 2017 Nov 24;40(12):714-718. doi: 10.5301/ijao.5000661. Epub 2017 Nov 16.

8.

Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.

Dozio E, Corradi V, Vianello E, Scalzotto E, de Cal M, Corsi Romanelli MM, Ronco C.

Mediators Inflamm. 2017;2017:9845175. doi: 10.1155/2017/9845175. Epub 2017 Sep 25.

9.

Structural basis for antibacterial peptide self-immunity by the bacterial ABC transporter McjD.

Bountra K, Hagelueken G, Choudhury HG, Corradi V, El Omari K, Wagner A, Mathavan I, Zirah S, Yuan Wahlgren W, Tieleman DP, Schiemann O, Rebuffat S, Beis K.

EMBO J. 2017 Oct 16;36(20):3062-3079. doi: 10.15252/embj.201797278. Epub 2017 Sep 1.

10.

Prospective, randomized, multicenter, controlled trial (TRIATHRON 1) on a new antithrombogenic hydrophilic dialysis membrane.

Ronco C, Brendolan A, Nalesso F, Zanella M, De Cal M, Corradi V, Virzì GM, Ferrari F, Garzotto F, Lorenzin A, Karopadi AN, Sartori M, De Rosa S, Samoni S, Husain-Syed F, Spinelli A, Neri M, Villa G, Alghisi A.

Int J Artif Organs. 2017 May 29;40(5):234-239. doi: 10.5301/ijao.5000608. [Epub ahead of print]

11.

Genetics and Autosomal Dominant Polycystic Kidney Disease Progression.

Corradi V, Giuliani A, Gastaldon F, de Cal M, Mancini B, Montaldi A, Alghisi A, Capelli I, La Manna G, Ronco C.

Contrib Nephrol. 2017;190:117-123. doi: 10.1159/000468956. Epub 2017 May 23. Review.

PMID:
28535524
12.

Predictors of rapid disease progression in autosomal dominant polycystic kidney disease.

Corradi V, Gastaldon F, Caprara C, Giuliani A, Martino F, Ferrari F, Ronco C.

Minerva Med. 2017 Feb;108(1):43-56. doi: 10.23736/S0026-4806.16.04830-8. Epub 2016 Oct 4. Review.

PMID:
27701376
13.

The Influence of Hemodialysis on T Regulatory Cells: A Meta-Analysis and Systematic Review.

Caprara C, Kinsey GR, Corradi V, Xin W, Ma JZ, Scalzotto E, Martino FK, Okusa MD, Nalesso F, Ferrari F, Rosner M, Ronco C.

Blood Purif. 2016;42(4):307-313. Epub 2016 Oct 1.

14.

Structural and Functional Basis for Lipid Synergy on the Activity of the Antibacterial Peptide ABC Transporter McjD.

Mehmood S, Corradi V, Choudhury HG, Hussain R, Becker P, Axford D, Zirah S, Rebuffat S, Tieleman DP, Robinson CV, Beis K.

J Biol Chem. 2016 Oct 7;291(41):21656-21668. Epub 2016 Aug 23.

15.

Copeptin levels and kidney function in ADPKD: case-control study.

Corradi V, Martino F, Gastaldon F, Scalzotto E, Caprara C, Fortunato A, Pinaffo G, Marchetti C, Fabbi F, Giavarina D, Ferrari F, Rosner MH, Ronco C.

Clin Nephrol. 2016 Sep;86(9):147-53. doi: 10.5414/CN108894.

PMID:
27487355
16.

The Heterodimeric ABC Transporter EfrCD Mediates Multidrug Efflux in Enterococcus faecalis.

Hürlimann LM, Corradi V, Hohl M, Bloemberg GV, Tieleman DP, Seeger MA.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5400-11. doi: 10.1128/AAC.00661-16. Print 2016 Sep.

17.

Optimizing a kidney stress test to evaluate renal functional reserve.

Sharma A, Zaragoza JJ, Villa G, Ribeiro LC, Lu R, Sartori M, Faggiana E, de Cal M, Virzi GM, Corradi V, Brocca A, Husain-Syed F, Brendolan A, Ronco C.

Clin Nephrol. 2016 Jul;86(7):18-26. doi: 10.5414/CN108497.

PMID:
27285313
18.

Probing catalytic rate enhancement during intramembrane proteolysis.

Arutyunova E, Smithers CC, Corradi V, Espiritu AC, Young HS, Tieleman DP, Lemieux MJ.

Biol Chem. 2016 Sep 1;397(9):907-19. doi: 10.1515/hsz-2016-0124.

PMID:
27071148
19.

Conformational Changes of the Antibacterial Peptide ATP Binding Cassette Transporter McjD Revealed by Molecular Dynamics Simulations.

Gu RX, Corradi V, Singh G, Choudhury HG, Beis K, Tieleman DP.

Biochemistry. 2015 Sep 29;54(38):5989-98. doi: 10.1021/acs.biochem.5b00753. Epub 2015 Sep 17.

PMID:
26334959
20.

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS.

Corradi V, Vergani P, Tieleman DP.

J Biol Chem. 2015 Sep 18;290(38):22891-906. doi: 10.1074/jbc.M115.665125. Epub 2015 Jul 30.

21.

[Plasma NGAL and ADPKD progression].

Virzì GM, Gastaldon F, Corradi V, de Cal M, Cruz DN, Clementi M, Ronco C.

G Ital Nefrol. 2015 May-Jun;32(3). pii: gin/32.3.9. Italian.

PMID:
26093138
22.

Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.

Corradi V, Gastaldon F, Virzì GM, Caprara C, Martino F, Ronco C.

Minerva Med. 2015 Feb;106(1):53-64. Epub 2014 Oct 10. Review.

PMID:
25300895
23.

[Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].

Virzì GM, Gastaldon F, Corradi V, de Cal M, Cruz DN, Clementi M, Ronco C.

G Ital Nefrol. 2013 Jul-Aug;30(4). pii: gin/30.4.7. Italian.

PMID:
24941494
24.

High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).

Virzì GM, Bruson A, Corradi V, Gastaldon F, de Cal M, Donà M, Cruz DN, Clementi M, Ronco C.

J Clin Lab Anal. 2014 Jul;28(4):328-34. doi: 10.1002/jcla.21689. Epub 2014 Mar 22.

PMID:
24658975
25.

Purity and stability of online-prepared hemodiafiltration fluid after storage.

Corradi V, Cruz D, Vázquez-Rangel A, Furlan F, Grillone R, Bonaccorsi A, Cazzavillan S, de Cal M, Frisone P, Morea A, Brendolan A, Rassu M, Ronco C.

Blood Purif. 2013;35(1-3):112-8. doi: 10.1159/000346095. Epub 2013 Jan 22.

26.

The human transporter associated with antigen processing: molecular models to describe peptide binding competent states.

Corradi V, Singh G, Tieleman DP.

J Biol Chem. 2012 Aug 10;287(33):28099-111. doi: 10.1074/jbc.M112.381251. Epub 2012 Jun 14.

27.

Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review.

Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA.

Am J Med. 2012 Jan;125(1):66-78.e3. doi: 10.1016/j.amjmed.2011.06.029. Review.

PMID:
22195531
28.

Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case.

Corradi V, Mancini M, Santucci MA, Carlomagno T, Sanfelice D, Mori M, Vignaroli G, Falchi F, Manetti F, Radi M, Botta M.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6867-71. doi: 10.1016/j.bmcl.2011.09.011. Epub 2011 Sep 10.

PMID:
21962576
29.

B-type natriuretic Peptide in the critically ill with acute kidney injury.

de Cal M, Haapio M, Cruz DN, Lentini P, House AA, Bobek I, Virzì GM, Corradi V, Basso F, Piccinni P, D'Angelo A, Chang JW, Rosner MH, Ronco C.

Int J Nephrol. 2011;2011:951629. doi: 10.4061/2011/951629. Epub 2011 Jun 22.

30.

ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Virzì GM, Corradi V, Panagiotou A, Gastaldon F, Cruz DN, de Cal M, Clementi M, Ronco C.

Int J Nephrol. 2010 Dec 21;2011:490795. doi: 10.4061/2011/490795.

31.

[Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?].

Corradi V, Gastaldon F, Virzi' GM, Clementi M, Nalesso F, Cruz DN, de Cal M, Torregrossa R, Ronco C.

G Ital Nefrol. 2010 Nov-Dec;27(6):655-63. Italian.

PMID:
21132648
32.

A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib.

Mancini M, Corradi V, Petta S, Barbieri E, Manetti F, Botta M, Santucci MA.

J Pharmacol Exp Ther. 2011 Mar;336(3):596-604. doi: 10.1124/jpet.110.172536. Epub 2010 Nov 1.

33.

Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis.

Corradi V, Mancini M, Manetti F, Petta S, Santucci MA, Botta M.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6133-7. doi: 10.1016/j.bmcl.2010.08.019. Epub 2010 Aug 8.

PMID:
20832303
34.

Removal of neutrophil gelatinase-associated lipocalin by extracorporeal therapies.

Bobek I, Gong D, De Cal M, Cruz D, Chionh CY, Haapio M, Soni SS, Nalesso F, Lentini P, Garzotto F, Corradi V, Ronco C.

Hemodial Int. 2010 Jul;14(3):302-7. doi: 10.1111/j.1542-4758.2010.00452.x. Epub 2009 May 23.

PMID:
20500227
35.

Markers of inflammation and oxidative stress in peritoneal dialysis: a comparison between high and low peritoneal transporters.

Cruz DN, Soni SS, Polanco N, Bobek I, Corradi V, de Cal M, Ronco C.

J Nephrol. 2010 Jul-Aug;23(4):453-8.

PMID:
20349414
36.

Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.

Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C.

Intensive Care Med. 2010 Mar;36(3):444-51. doi: 10.1007/s00134-009-1711-1. Epub 2009 Dec 3.

37.

Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy.

Corradi V, Gastaldon F, Virzì GM, de Cal M, Soni S, Chionh C, Cruz DN, Clementi M, Ronco C.

Clin Nephrol. 2009 Oct;72(4):259-67.

PMID:
19825331
38.

mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein.

Mancini M, Corradi V, Petta S, Martinelli G, Barbieri E, Santucci MA.

Leuk Res. 2010 May;34(5):641-8. doi: 10.1016/j.leukres.2009.07.012. Epub 2009 Jul 29.

PMID:
19643477
39.

New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells.

Santucci MA, Mancini M, Corradi V, Lacobucci I, Martinelli G, Botta M, Schenone S.

Invest New Drugs. 2010 Dec;28(6):876-8. doi: 10.1007/s10637-009-9294-9. Epub 2009 Jul 24. No abstract available.

PMID:
19629392
40.

NGAL: a biomarker of acute kidney injury and other systemic conditions.

Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, de Cal M, Corradi V, Virzi G, Ronco C.

Int Urol Nephrol. 2010 Mar;42(1):141-50. doi: 10.1007/s11255-009-9608-z. Epub 2009 Jul 7. Review.

PMID:
19582588
41.

14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.

Mancini M, Veljkovic N, Corradi V, Zuffa E, Corrado P, Pagnotta E, Martinelli G, Barbieri E, Santucci MA.

Traffic. 2009 Jun;10(6):637-47. doi: 10.1111/j.1600-0854.2009.00897.x. Epub 2009 Feb 11.

42.

C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines.

Santucci MA, Corradi V, Mancini M, Manetti F, Radi M, Schenone S, Botta M.

ChemMedChem. 2009 Jan;4(1):118-26. doi: 10.1002/cmdc.200800320.

PMID:
19039816
43.

Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.

Tintori C, Corradi V, Magnani M, Manetti F, Botta M.

J Chem Inf Model. 2008 Nov;48(11):2166-79. doi: 10.1021/ci800105p.

PMID:
18942779
44.

Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study.

Cruz DN, De Cal M, Garzotto F, Brendolan A, Nalesso D, Corradi V, Ronco C.

Int J Artif Organs. 2008 Jun;31(6):545-52.

PMID:
18609507
45.

HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.

de Cal M, Cruz DN, Corradi V, Nalesso F, Polanco N, Lentini P, Brendolan A, Tetta C, Ronco C.

Blood Purif. 2008;26(3):249-54. doi: 10.1159/000122110. Epub 2008 Mar 29.

PMID:
18376106
46.

IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia.

Mancini M, Zuffa E, Veljkovic N, Brusa G, Corrado P, Corradi V, Martinelli G, Barbieri E, Santucci MA.

Br J Haematol. 2008 Jun;141(6):899-902. doi: 10.1111/j.1365-2141.2008.07134.x. Epub 2008 Mar 27. No abstract available.

PMID:
18373703
47.

Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.

Grohmann D, Corradi V, Elbasyouny M, Baude A, Horenkamp F, Laufer SD, Manetti F, Botta M, Restle T.

Chembiochem. 2008 Apr 14;9(6):916-22. doi: 10.1002/cbic.200700669.

PMID:
18318036
48.

Oxidative stress and 'monocyte reprogramming' in septic patients with acute kidney injury requiring CRRT.

Silva S, de Cal M, Cruz D, Lentini P, Corradi V, Gallo G, Salvatori G, Verbine A, Pogoshyan L, Nalesso F, Brendolan A, Piccinni P, Ronco C.

Blood Purif. 2008;26(2):188-92. doi: 10.1159/000117308. Epub 2008 Feb 15.

PMID:
18277069
49.

Oxidative stress and 'monocyte reprogramming' after kidney transplant: a longitudinal study.

de Cal M, Silva S, Cruz D, Basso F, Corradi V, Lentini P, Nalesso F, Dissegna D, Goepel V, Chiaramonte S, Ronco C.

Blood Purif. 2008;26(1):105-10. doi: 10.1159/000110575. Epub 2008 Jan 10.

PMID:
18182807
50.

Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents.

Radi M, Crespan E, Botta G, Falchi F, Maga G, Manetti F, Corradi V, Mancini M, Santucci MA, Schenone S, Botta M.

Bioorg Med Chem Lett. 2008 Feb 1;18(3):1207-11. Epub 2007 Dec 4.

PMID:
18078752

Supplemental Content

Loading ...
Support Center